The objective of the study was to investigate the antimicrobial effects of purified single compounds from ethanol-extracted licorice root on Streptococcus mutans. The crude licorice root extract (CLE) was obtained from Glycyrrhiza uralensis, which was subjected to column chromatography to separate compounds. Purified compounds were identified by mass spectrometry and nuclear magnetic resonance. Antimicrobial activities of purified compounds from CLE were evaluated by determining the minimum inhibitory concentration and by performing time-kill kinetics. The inhibitory effects of the compounds on biofilm development were evaluated using crystal violet assay and confocal microscopy. Cell toxicity of substances to normal human gingival fibroblast (NHGF) cells was tested using a methyl thiazolyl tetrazolium assay. Chlorhexidine digluconate (CHX) was used in the control group. Three antimicrobial flavonoids, 1-methoxyficifolinol, licorisoflavan A, and 6,8-diprenylgenistein, were isolated from the CLE. We found that the three flavonoids and CHX had bactericidal effects on S. mutans UA159 at the concentration of ≥4 and ≥1 µg/ml, respectively. The purified compounds completely inhibited biofilm development of S. mutans UA159 at concentrations over 4 μg/ml, which was equivalent to 2 μg/ml of CHX. Confocal analysis showed that biofilms were sparsely scattered in the presence of over 4 μg/ml of the purified compounds. However, the three compounds purified from CLE showed less cytotoxic effects on NHGF cells than CHX at these biofilm-inhibitory concentrations. Our results suggest that purified flavonoids from CLE can be useful in developing oral hygiene products, such as gargling solutions and dentifrices for preventing dental caries.

1.
Ahn SJ, Cho EJ, Kim HJ, Park SN, Lim YK, Kook JK: The antimicrobial effects of deglycyrrhizinated licorice root extract on Streptococcus mutans UA159 in both planktonic and biofilm cultures. Anaerobe 2012;18:590-596.
2.
Ahn SJ, Wen ZT, Brady LJ, Burne RA: Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun 2008;76:4259-4268.
3.
Asl MN, Hosseinzadeh H: Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 2008;22:709-724.
4.
Chukwujekwu JC, Van Heerden FR, Van Staden J: Antibacterial activity of flavonoids from the stem bark of Erythrina caffra thunb. Phytother Res 2011;25:46-48.
5.
Fukai T, Oku Y, Hano Y, Terada S: Antimicrobial activities of hydrophobic 2-arylbenzofurans and an isoflavone against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Planta Med 2004;70:685-687.
6.
Gafner S, Bergeron C, Villinski JR, Godejohann M, Kessler P, Cardellina JH, Ferreira D, Feghali K, Grenier D: Isoflavonoids and coumarins from Glycyrrhizauralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification. J Nat Prod 2011;74:2514-2519.
7.
Glassman P: Practical protocols for the prevention of dental disease in community settings for people with special needs: preface. Spec Care Dent 2003;23:157-159.
8.
Hatano T, Aga Y, Shintani Y, Ito H, Okuda T, Yoshida T: Minor flavonoids from licorice. Phytochemistry 2000a;55:959-963.
9.
Hatano T, Shintani Y, Aga Y, Shiota S, Tsuchiya T, Yoshida T: Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone, and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus. Chem Pharm Bull (Tokyo) 2000b;48:1286-1292.
10.
He J, Chen L, Heber D, Shi W, Lu QY: Antibacterial compounds from Glycyrrhizauralensis. J Nat Prod 2006;69:121-124.
11.
Kim MJ, Kim CS, Park JY, Park SN, Yoo SY, Lee SY, Kook JK: Bacterial model system for screening and determining optimal concentration of anti-caries natural extracts. J Microbiol 2011;49:165-168.
12.
Kiuchi F, Xing C, Tsuda Y: Four new phenolic constituents from licorice (root of Glycyrrhiza sp). Heterocycles 1990;31:629-636.
13.
Koehn FE, Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005;4:206-220.
14.
Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986;50:353-380.
15.
National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M7-A5. Wayne, National Committee for Clinical Laboratory Standards, 2003.
16.
Paula VA, Modesto A, Santos KR, Gleiser R: Antimicrobial effects of the combination of chlorhexidine and xylitol. Br Dent J 2010;209:E19.
17.
Pecharki D, Petersen FC, Assev S, Scheie AA: Involvement of antigen I/II surface proteins in Streptococcus mutans and Streptococcus intermedius biofilm formation. Oral Microbiol Immunol 2005;20:366-371.
18.
Petti S, Hausen H: Caries-preventive effect of chlorhexidine gel applications among high-risk children. Caries Res 2006;40:514-521.
19.
Quirynen M, Bollen CM: The influence of surface roughness and surface-free energy on supra- and subgingival plaque formation in man. A review of the literature. J Clin Periodontol 1995;22:1-14.
20.
Shih LY, Wu JJ, Yang DJ: Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res 1987;225:238-246.
21.
Sletten GB, Dahl JE: Cytotoxic effects of extracts of compomers. Acta Odontol Scand 1999;57:316-322.
22.
Takahashi N, Nyvad B: The role of bacteria in the caries process: ecological perspectives. J Dent Res 2011;90:294-303.
23.
Tsuchiya H, Sato M, Miyazaki T, Fujiwara S, Tanigaki S, Ohyama M, Tanaka T, Iinuma M: Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol 1996;50:27-34.
24.
Van Strydonck DA, Slot DE, Van der Velden U, Van der Weijden F: Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. J Clin Periodontol 2012;39:1042-1055.
25.
Wen D, Liu Y, Li W, Liu H: Separation methods for antibacterial and antirheumatism agents in plant medicines. J Chromatogr B Analyt Technol Biomed Life Sci 2004;812:101-117.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.